Rocket


News + Filings
Transactions





SEIDENBERG BETH C

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/31/2023Atara Biotherapeutics, Inc.ATRAGrantCommon Stock57k$0.00$0 05/31/2023
05/31/2023Atara Biotherapeutics, Inc.ATRAGrantNon-Qualified Stock Option (Right to Buy)79.5k$1.53$121.6k 05/31/2023
05/24/2023Progyny, Inc.PGNYGrantCommon Stock5.1k$0.00$0 05/24/2023
05/24/2023Progyny, Inc.PGNYGrantStock Option (Right to Buy)19.7k$38.24$753.7k 05/24/2023
05/24/2023Progyny, Inc.PGNYGrantStock Option (Right to Buy)3.3k$38.24$124.7k 05/24/2023
05/10/2023Vera Therapeutics, Inc. GrantStock Option (right to buy)20k$7.70$154k 05/10/2023
05/09/2023ACELYRIN, Inc. ConversionSeries B Redeemable Convertible Preferred Stock2.4M$0.00$0See footnote05/09/2023
05/09/2023ACELYRIN, Inc. ConversionSeries C Redeemable Convertible Preferred Stock2M$0.00$0See footnote05/09/2023
05/09/2023ACELYRIN, Inc. ConversionSeries A Redeemable Convertible Preferred Stock4.1M$0.00$0See footnote05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock60k$18.00$1.1M 05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock1.2M$18.00$22.5MSee footnote05/09/2023
05/09/2023ACELYRIN, Inc. ConversionCommon Stock8.5M$0.00$0See footnote05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/04/2023ACELYRIN, Inc. GrantDirector Stock Option (right to buy)23.2k$18.00$418.4k 05/04/2023
03/30/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock2.3k$7.24$16.7kSee Footnote03/30/2023
03/20/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock15.3k$7.21$110kSee Footnote03/17/2023
03/17/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock74k$7.12$526.9kSee Footnote03/17/2023
03/16/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock60.1k$7.09$426.3kSee Footnote03/15/2023
03/15/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock32.8k$7.12$234kSee Footnote03/15/2023
03/03/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock1000$7.25$7.2kSee footnote03/03/2023
02/23/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock200$7.24$1.4kSee footnote02/23/2023
02/08/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock45.4k$7.22$327.5kSee footnote02/03/2023
02/07/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock88k$7.08$622.7kSee footnote02/03/2023
02/06/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock131.6k$7.03$925.2kSee footnote02/03/2023
02/03/2023Vera Therapeutics, Inc. PurchaseClass A Common Stock46.2k$7.24$334.2kSee footnote02/03/2023
10/24/2022Progyny, Inc.PGNYGrantStock Option (Right to Buy)1.9k$38.22$72.5k 10/24/2022
10/24/2022Progyny, Inc.PGNYGrantCommon Stock4.1k$0.00$0 10/24/2022
10/24/2022Progyny, Inc.PGNYGrantStock Option (Right to Buy)16.8k$38.22$642.9k 10/24/2022
06/23/2022Atara Biotherapeutics, Inc.ATRAGrantCommon Stock20.5k$0.00$0 06/23/2022
06/23/2022Atara Biotherapeutics, Inc.ATRAGrantNon-Qualified Stock Option (Right to Buy)31.5k$7.35$231.5k 06/23/2022
05/24/2022Vera Therapeutics, Inc. GrantStock Option (right to buy)9.9k$16.14$160.2k 05/24/2022
03/03/2022Progyny, Inc.PGNYGiftCommon Stock23k$0.00$0 10/24/2022
03/03/2022Progyny, Inc.PGNYGiftCommon Stock23k$0.00$0See footnote10/24/2022
12/22/2021Progyny, Inc.PGNYOther (disposition)Common Stock19.3k$0.00$0See footnote12/22/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy